- 2016. Diabetes Australia. Determining the cellular mechanisms of insulin resistance in obese women who develop gestational diabetes: Placenta-derived exosome, a possible biomarker for the early detection of gestational diabetes.
- 2017. Bill & Melissa Gates Foundation. Profiling of Placental Physiologic Signature During Pregnancy in Maternal Liquid Biopsies.
- 2016-2017. UQ-Ochsner Seed Fund. Placenta-derived exosomes, a possible biomarker for early detection of preeclampsia.
- 2016-2017. UQ-Ochsner Seed Fund for Collaborative Research, Ochsner Medical Center and University of Queensland. ‘MicroRNA and proteomic signatures of tumour-derived exosomes as early diagnostic tool of ovarian cancer progression’.
- 2015-2016. Exosomes as potential biomarkers for pancreatic cyst risk stratification for Pancreatic cancer. Funding source: 2015 Academic Title Holder Research Fund Scheme.
- 2015-2018. Tumor-derived exosomes and ovarian cancer. Funding source: generic donation.
- 2016-2019. NHMRC development grant (APP1114013). In vitro diagnostic for first trimester risk assignment of gestational diabetes.
- 2016 M+BS Emerging Leaders Medical Research Grant, titled Identification of exosomal miRNA targets involved in drug resistance in ovarian cancer.
- 2016 Brisbane Diamantina Health Partners (BDHP) Strategic Initiative Grant Scheme. The Queensland Gynaecological Cancer Initiative.
- 2016 UQ FirstLink Scheme. Large scale production and purification of placental exosomes with clinical Good Manufacturing Practice (GMP)-grade for biomarker applications.
Projects available for students
- Gestational diabetes
- Preeclampsia
- Preterm birth
- In vitro fertilisation
- Ovarian cancer
- Colon cancer
- Pancreatic cancer
- Obesity and cancer
- Obesity and complication of pregnancies